Philip T. Sager

Philip T. Sager is a Scientific Advisor at CinCor Pharma. Philip has also served as a Member and Chair of the FDA Cardio-Renal Advisory Committee, VP and Head of CardioPulmonary and Metabolic Clinical Development at Gilead Sciences, and Chief Medical Officer at CardioDx. Dr. Sager has also been an Executive Director at AstraZeneca and Schering-Plough, and a Director of CV Research at Schering-Plough.

Philip T. Sager is a medical doctor who specializes in cardiology and cardiac electrophysiology. Philip attended Yale University School of Medicine for their MD and BS degrees in chemistry and biology, respectively. Prior to that, they attended the Massachusetts Institute of Technology for their BS degree in chemistry and biology. Philip also attended the Dalton School for high school.